Top 20 Companies in Pharmaceutical and Biotechnology Market 2025: Strategic Overview and Future Trends (2024–2035)
RELEASE DATE: Mar 2026 Author: Spherical InsightsRequest Free Sample Speak to Analyst
Description
According to a research report published by Spherical Insights & Consulting, The Global Pharmaceutical & Biotechnology Market Size Is Projected To Grow From USD 3.37 Trillion In 2024 To USD 8.05 Trillion By 2035, At A CAGR Of 8.24% During The Forecast Period 2024–2035. The market is being driven by the rising prevalence of chronic diseases, growing acceptance of biologics and biosimilars, increasing investment by governments globally in research and development to address unmet medical needs and promote innovation, expansion of product portfolios by companies, and emerging research and development hubs.
Introduction
The global pharmaceutical biotechnology market represents the segment of the healthcare industry where biological systems and organisms are used to develop, formulate, and manufacture medical products. Pharmaceuticals denote medicinal drugs while biotechnology describes the process of using biological research to create products from living organisms. Pharmaceutical biotechnology refers to the process of applying biotechnology for drug development purposes. The research in pharmaceutical biotechnology investigates multiple aspects of drug development and pharmacological studies which include in vitro and preclinical and clinical research. The economic strength of Germany together with its advanced technology capabilities makes Germany the perfect site for conducting pharmaceutical and medical technology research and development activities.
KALA BIO, Inc. will deliver its first commercial artificial intelligence product within two weeks according to their announcement from March 2026, which marks their transition from a clinical-stage biotech company to a dual-growth enterprise that operates through its proprietary drug development and its artificial intelligence platform designed for the $180 billion healthcare AI market. Astellas Pharma Inc. and Vir Biotechnology established a worldwide strategic partnership in February 2026 to develop VIR-5500, which is an experimental PRO-XTEN dual-masked CD3 T-cell engager that targets PSMA for prostate cancer treatment.
Navigate Future Markets with Confidence: Insights from Spherical Insights LLP
The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the pharmaceutical & biotechnology market.
Pharmaceutical & Biotechnology Market Size & Statistics
- The Market Size for Pharmaceutical & Biotechnology Was Estimated to be worth USD 3.37 trillion in 2024.
- The Market is Going to Expand at a CAGR of 8.24% between 2024 and 2035.
- The Global Pharmaceutical & Biotechnology Market Size is anticipated to reach USD 8.05 trillion by 2035.
- North America is expected to generate the highest demand during the forecast period in the Pharmaceutical & Biotechnology Market
- Europe is expected to grow the fastest during the forecast period in the Pharmaceutical & Biotechnology Market.
Regional growth and demand
Europe is expected to grow the fastest during the forecast period in the pharmaceutical & biotechnology market. Europe is projected to grow fastest due to this region’s presence of robust research institutions and universities, strong regulatory frameworks, such as the European Medicines Agency (EMA), and substantial public and private investments. The presence of a skilled workforce, strong collaboration between academia, industry, and healthcare institutions, and favorable government support and funding also promote market growth in Europe.
North America is expected to generate the highest demand during the forecast period in the pharmaceutical & biotechnology market. North America is expected to generate the highest demand due to this region’s robust research and development infrastructure, significant investment in healthcare, a high prevalence of chronic diseases, and the presence of major pharmaceutical and biotechnology companies.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the pharmaceutical & biotechnology market.
Ready to lead the Global Pharmaceutical & Biotechnology Market?
Discover the regional trends and growth factors shaping the industry. We’re here to assist with expert, personalized data.
Call +1 303 800 4326 or Send us a message for a personalized consultation.
Top 10 Trends in the Pharmaceutical & Biotechnology Market
- AI-Driven Drug Discovery and R&D
- Cell and Gene Therapies (CGTs) Expansion
- Rise of GLP-1 and Metabolic Drugs
- Decentralized Clinical Trials (DCTs)
- Precision Medicine and Personalization
- "Around the Pill" Digital Health Strategies
- Advanced Manufacturing
- Sustainability and Green Chemistry
- Geopolitical Reshoring and Supply Chain Resilience
- Rise of Antibody-Drug Conjugates (ADCs) and Bispecifics
1. AI-Driven Drug Discovery and R&D
Artificial Intelligence is moving from pilot projects to a core, end-to-end component of drug discovery, shortening timelines from years to months. AI is being used for target identification, molecular simulation, and accelerating clinical trials by streamlining patient recruitment and data analysis.
2. Cell and Gene Therapies (CGTs) Expansion
Gene editing (CRISPR) and cell therapies (CAR-T) are moving from niche to mainstream, offering potential cures rather than just treatments for rare diseases and cancer. By 2025, 10–20 new gene therapies are expected to be approved annually.
3. Rise of GLP-1 and Metabolic Drugs
GLP-1 receptor agonists (e.g., Wegovy, Ozempic, Zepbound) have become a massive, lucrative market, with research expanding into treating cardiovascular disease, Alzheimer's, and addiction.
4. Decentralized Clinical Trials
To improve patient access and diversity, trials are increasingly utilizing remote monitoring, wearable devices, and telehealth. This "virtual" approach reduces reliance on traditional site visits..
5. Precision Medicine and Personalization
Treatments are being tailored to individual genetic profiles and biomarkers, particularly in oncology and immunology, driven by lower costs for DNA sequencing and advanced diagnostics.
Empower your strategic planning:
Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the pharmaceutical & biotechnology market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.
Top 20 Companies Leading the Pharmaceutical & Biotechnology Market
- Eli Lilly and Company
- Johnson & Johnson
- AbbVie Inc.
- F. Hoffmann-La Roche Ltd.
- AstraZeneca PLC
- Novartis AG
- Novo Nordisk A/S
- Merck & Co., Inc.
- Amgen Inc.
- Gilead Sciences, Inc.
- Pfizer Inc.
- Sanofi S.A.
- Vertex Pharmaceuticals Incorporated
- Bristol Myers Squibb Company
- CSL Limited
- GlaxoSmithKline plc
- Chugai Pharmaceutical Co., Ltd.
- Zoetis Inc.
- Regeneron Pharmaceuticals, Inc.
- Biogen Inc.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the pharmaceutical & biotechnology market.
1. Eli Lilly and Company
Headquarters: Indianapolis, United States
Eli Lilly and Company is a global pharmaceutical company headquartered in Indianapolis, United States. The company focuses on discovering, developing, and manufacturing medicines for diseases such as diabetes, cancer, and neurological disorders. Lilly is widely known for its diabetes treatments and innovative research in biotechnology. The company invests heavily in research and development to create advanced therapies that improve patient outcomes worldwide.
2. Johnson & Johnson.
Headquarters: New Brunswick, New Jersey
Johnson & Johnson is one of the world’s largest healthcare companies, headquartered in New Brunswick, New Jersey. The company operates in pharmaceuticals, medical devices, and consumer health products. Johnson & Johnson develops medicines for areas such as oncology, immunology, and infectious diseases. The company is also known for producing widely used healthcare and personal care products. With a strong global presence and a long history of innovation, Johnson & Johnson plays a key role in improving healthcare systems and patient care worldwide.
3. Novo Nordisk
Headquarters: Bagsværd, Denmark
Novo Nordisk is a leading global healthcare company headquartered in Bagsværd, Denmark. The company specializes in diabetes care and is also active in obesity treatment, hemophilia, and rare diseases. Novo Nordisk is well known for developing innovative insulin products and advanced therapies that help millions of patients manage chronic conditions. The company focuses strongly on biotechnology research and sustainable healthcare solutions.
4. AbbVie
Headquarters: North Chicago, Illinois
AbbVie is a global biopharmaceutical company headquartered in North Chicago, Illinois. It was founded in 2013 as a spin-off from Abbott Laboratories. AbbVie focuses on developing innovative medicines in areas such as immunology, oncology, neuroscience, and eye care. The company is widely known for its blockbuster drugs used to treat autoimmune diseases and other chronic conditions. AbbVie invests heavily in scientific research and new drug development to address complex health issues.
5. AstraZeneca
Headquarters: Cambridge, United Kingdom
AstraZeneca is a major global pharmaceutical company headquartered in Cambridge, United Kingdom. The company focuses on developing medicines for oncology, cardiovascular diseases, respiratory disorders, and rare diseases. AstraZeneca gained global attention for developing a COVID-19 vaccine in partnership with the University of Oxford. The company is known for strong investment in scientific research and innovation, helping advance new treatments that improve health outcomes worldwide.
Are you ready to discover more about the pharmaceutical & biotechnology market?
The report provides an in-depth analysis of the leading companies operating in the global pharmaceutical & biotechnology market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:
Company Profiles
- Eli Lilly and Company
- Business Overview
- Company Snapshot
- Products Overview
- Company Market Share Analysis
- Company Coverage Portfolio
- Financial Analysis
- Recent Developments
- Merger and Acquisitions
- SWOT Analysis
- Johnson & Johnson
- Novo Nordisk
- AbbVie
- AstraZeneca
- Novartis
- Merck & Co.
- Pfizer
- Vertex Pharmaceuticals
- Regeneron Pharmaceuticals
- Others
Our Reports
https://www.sphericalinsights.com/reports/japan-agricultural-microbial-market
https://www.sphericalinsights.com/reports/japan-combine-harvester-market
https://www.sphericalinsights.com/reports/japan-blockchain-technology-healthcare-market
https://www.sphericalinsights.com/reports/india-styrene-acrylonitrile-market
https://www.sphericalinsights.com/reports/india-psoriasis-drugs-market
Conclusion
The pharmaceutical and biotechnology market is experiencing significant transformation driven by scientific innovation, digital technologies, and increasing global healthcare demand. Advancements in biologics, gene therapies, precision medicine, and AI-driven drug discovery are reshaping how treatments are developed and delivered. Strategic collaborations, expanding research pipelines, and investments in advanced manufacturing are strengthening the competitive landscape. In addition, the growing focus on personalized healthcare and decentralized clinical trials is improving patient access and treatment effectiveness. Leading companies continue to accelerate innovation through research partnerships and technological integration, positioning the industry for sustained long-term growth and improved healthcare outcomes across diverse therapeutic areas worldwide.
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?